Structural abnormalities in white matter, even before the onset of inflammation, may serve as a new therapeutic target for multiple sclerosis (MS). The study, focusing on 'normal-appearing white matter', identified early changes in myelin, an insulating substance around nerve fibers.
from Neuroscience News https://ift.tt/zcGLXP6
from Neuroscience News https://ift.tt/zcGLXP6
Comments
Post a Comment